| | |

Socioeconomic Factors Shape Mesothelioma Outcomes

Socioeconomic Factors Shape Mesothelioma Outcomes

Socioeconomic and racial factors can play a role in the survival rates of patients with mesothelioma.

This finding was presented by a team of researchers at the 2023 annual meeting of the American Society of Clinical Oncology.

Mesothelioma Survival Rates

Mesothelioma is a rare and aggressive type of cancer caused by asbestos exposure. It mostly affects the lining of the lungs, but also occurs in the abdomen. It is diagnosed in around 2,000 people in the United States each year, which is a very small percentage of all cancer cases.

The outlook for people with mesothelioma is not good, with only 7 to 10% of patients surviving for five years. The disease is usually diagnosed when people are older because it takes a long time for symptoms to appear.

Exploring the Influence of Race and Socioeconomic Status

A group of researchers wanted to study how different factors. These included race and socioeconomic status. They can affect the chances of survival for patients with mesothelioma. They looked at information from a large database that collects data on cancer cases. The study included 13,166 patients diagnosed with mesothelioma between 2000 and 2019.

When it came to the stage of the disease at diagnosis, the Black patients in the study had a higher percentage of cases that had spread to other parts of the body compared to White and Asian/Pacific Islander patients.

The study also looked at income levels. The researchers found that a larger number of Black patients had a household income below $65,000 compared to White and Asian/Pacific Islander patients. The researchers also noticed that a smaller number of Black patients were married at the time of diagnosis compared to the other racial groups.

In terms of treatment, chemotherapy was the most common option. It was followed by surgery and radiation. However, the researchers found that a higher percentage of Black patients did not receive any treatment compared to the other racial groups.

When looking at survival rates, the study found that Black patients had the lowest rates compared to White and Asian/Pacific Islander patients. After one year, only 29% of Black patients were still alive, while 33.2% of White patients and 31% of Asian/Pacific Islander patients survived. The rates continued to drop at the three-year and five-year marks for all racial groups.

The researchers concluded that factors like race and income can affect the overall survival of mesothelioma patients. This disparity may be due to factors such as the disease being diagnosed at a later stage, lower rates of marriage, lower household income, and limited access to treatment options.

Source

Patel D, Yadukumar L, Dourado CM, Leighton JC. Demographic and racial characteristics, and survival trends in pleural mesothelioma: A population based study [abstract taken from J Clin Oncol. 2023;41(16): e20543-e20543]. https://ascopubs.org/doi/abs/10.1200/JCO.2023.41.16_suppl.e20543

Similar Posts

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…

  • |

    Mesothelioma Blood Test May Be Possible

    An international team of researchers is studying the proteins found on the surface of cancer cells in an effort to improve mesothelioma diagnosis. The team, made up of scientists from the US, Switzerland, Italy and Chile, has just published their findings on a new kind of test to identify protein-derived mesothelioma biomarkers in blood serum. Mesothelioma is an aggressive cancer of the membranes around organs. Because the most common mesothelioma biomarker, mesothelin, is also overproduced by other kinds of cancer cells, it has only limited diagnostic value. A test to identify a set of proteins produced specifically by mesothelioma cells could greatly improve diagnostic accuracy. Led by Ferdinando Cerciello and Bernd Wollscheid of the Institute of Molecular Systems Biology in…

  • | |

    Micro-RNAs May Offer New Way to Fight Mesothelioma

    Scientists at one of the world’s top mesothelioma research centers, the Asbestos Diseases Research institute in Sydney, Australia, say that restoring the expression of certain micro RNAs in the cells of mesothelioma patients may offer a new way to fight the disease. A microRNA is a small RNA molecule which is involved in the regulation of gene expression. According to a new report in the Annals of Oncology, the Australian scientists found reduced expression of the micro RNA-15 family (miR-15/16) in the cells of mice with mesothelioma. “When malignant pleural mesothelioma cell lines were compared with the normal mesothelial cell line MeT-5A, the downregulation of miR-15/16 was 2- to 10-fold,” they report. This finding is consistent with previous cancer research…

  • |

    Mesothelioma Still Carries Heavy Mortality Burden in U.S.

    Asbestos exposure cost Americans more than 427,000 years of potential life in the first decade of the new millennium. That figure comes from a study on mesothelioma and asbestosis – the two most deadly asbestos-related diseases – conducted by the CDC’s National Institute for Occupational Safety and Health (NIOSH). Using National Center for Health Statistics mortality data, NIOSH researchers evaluated premature deaths and “loss of potentially productive years of life” attributable to either asbestosis or mesothelioma between 1999 and 2010. The data included only people 25 years or older with an underlying cause of death listed on their death certificate of either asbestosis or malignant mesothelioma. When the figures were calculated using the normal life expectancy for each asbestosis victim…

  • | |

    Needle Biopsy “Simple, Safe & Accurate” for Mesothelioma

    Mesothelioma researchers in China say a biopsy method that involves a single skin puncture can produce good diagnostic results for mesothelioma patients with little pain or risk. The study focused on percutaneous (through the skin) biopsy in patients who had unexplained fluid buildup or swelling in their abdomens. Abdominal distension and fluid buildup (called ascites) can be signs of peritoneal mesothelioma, a rare but aggressive cancer of the abdominal lining caused by exposure to asbestos. Peritoneal mesothelioma accounts for less than 30% of all mesothelioma cases. Because the symptoms may be vague and often develop many decades after asbestos exposure, peritoneal mesothelioma can be especially challenging to diagnose.  Misdiagnosis and under-diagnosis are not uncommon. In the newest study on percutaneous…

  • | |

    Treatment Uses Herpes Virus to Shrink Mesothelioma Tumors

    Researchers at a hospital in Sheffield, England are testing a potential new mesothelioma treatment based on the same virus that causes herpes. The small-scale trial is the first in the world to test the modified herpes simplex virus, HSV1716, in human mesothelioma patients. HSV1716 has been genetically engineered to infect and kill cancer cells without harming healthy cells. In laboratory studies on mesothelioma and some other cancers, it has been shown to be effective at shrinking tumors while causing limited toxicity. Just as significantly, HSV1716 increased survival rates among mice with various human cancers. The Phase I/II trial at Sheffield Experimental Cancer Medicine Centre is the next stage in development of HSV1716 as a viable mesothelioma treatment. The goal of…